Durvalumab vs Trazodone

## Durvalumab vs Trazodone: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Trazodone**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Trazodone**: Serotonin antagonist and reuptake inhibitor (SARI).

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Trazodone — 5-9 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Trazodone — C19H22ClN5O.

**Molecular Weight**: Durvalumab — N/A; Trazodone — 371.8640 g/mol.

**Type**: Durvalumab — Antibody; Trazodone — Small molecule.